These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32308577)

  • 1. Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis.
    Wongjirattikarn R; Chaowattanapanit S; Choonhakarn C; So-Ngern A; Mahakkanukrauh A; Foocharoen C
    Case Rep Dermatol; 2020; 12(1):57-63. PubMed ID: 32308577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.
    Dunga SK; Kavadichanda C; Gupta L; Naveen R; Agarwal V; Negi VS
    Rheumatol Int; 2022 Jul; 42(7):1155-1165. PubMed ID: 34050793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
    Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedo Racemosa, Reticulated Ulcerations, Panniculitis and Violaceous Plaques in a 46-year-old Woman.
    Agulló A; Hinds B; Larrea M; Yanguas I
    Indian Dermatol Online J; 2018; 9(1):47-49. PubMed ID: 29441299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study.
    Weng C; Ding Z; Zhou Y; Yang Q; Xue L; Zhang L; Wang G; Liu Z
    Rheumatol Ther; 2023 Jun; 10(3):635-648. PubMed ID: 36802052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report.
    Yen TH; Tseng CW; Wang KL; Fu PK
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
    Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
    Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-MDA5 dermatomyositis. Literature review].
    Castro-Molina SA; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):99-105. PubMed ID: 36542793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis.
    Hamada-Ode K; Taniguchi Y; Kimata T; Kawaguchi Y; Shimamura Y; Kuwana M; Fujimoto S; Terada Y
    Eur J Rheumatol; 2015 Jun; 2(2):83-85. PubMed ID: 27708934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic.
    Gupta P; Kharbanda R; Lawrence A; Gupta L
    Egypt Rheumatol; 2021 Oct; 43(4):271-274. PubMed ID: 36536808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports.
    Takahashi R; Yoshida T; Morimoto K; Kondo Y; Kikuchi J; Saito S; Ishigaki S; Kaneko Y; Takeuchi T; Itoh H; Oya M
    Clin Med Insights Case Rep; 2021; 14():11795476211036322. PubMed ID: 34377045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
    Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative Heliotrope Rash in Antimelanoma Differentiation-Associated Gene 5 Dermatomyositis.
    Daugherty TT; Cheeley JT
    Cutis; 2021 May; 107(5):E5-E8. PubMed ID: 34288860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C; Vincent T; Bessis D
    Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of Anti-melanoma differentiation-associated gene 5 (MDA-5) antibody-positive dermatomyositis with rapidly progressive interstitial lung disease complicated by bilateral breast cancer following the additional tofacitinib: A case report.
    Yamane T; Kitayama M
    Mod Rheumatol Case Rep; 2024 Sep; ():. PubMed ID: 39330992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review.
    Ogawa Y; Kishida D; Shimojima Y; Hayashi K; Sekijima Y
    Case Rep Rheumatol; 2017; 2017():5386797. PubMed ID: 29225988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.